Stockscreener 앱 받기
1.41
8.44%
-0.13
시장 영업 전:
1.49
0.08
+5.67%
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
Mira Pharmaceuticals (MIRA) Price Target Increased by 37.58% to 23.15 - MSN
MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain - Mugglehead
MIRA Pharmaceuticals Shares Surge 40% After Ketamir-2 Excels in Pain Management Trials - Yahoo Finance
CECO (NASDAQ:CECO) Reports Sales Below Analyst Estimates In Q3 Earnings, Stock Drops 10.6% - Barchart
SoFi Stock Jumps As CEO Hails 'Strongest Quarter In Our History': Retail Confidence Grows - Barchart
Here's What To Expect From Cintas' Next Earnings Report - Barchart
H&E Equipment Services (NASDAQ:HEES) Misses Q3 Sales Targets - Barchart
Janus (NYSE:JBI) Misses Q3 Sales Targets, Stock Drops 13.2% - Barchart
What To Expect From NVIDIA's Next Quarterly Earnings Report - Barchart
What You Need To Know Ahead Of Applied Materials' Earnings Release - Barchart
Small And Micro-Cap Movers: Key News, Market Reactions, And Insider Chatter - Barchart
Warren Buffett Loves SiriusXM, But These 2 Media Stocks Are Better Buys - Barchart
Tiny Healthcare Stock With $35 Million Market Cap Becomes Major Player Overnight In Rapidly Growing $1 Billion Market - Barchart
Teladoc (TDOC) To Report Earnings Tomorrow: Here Is What To Expect - Barchart
Winners For 2024 Webster Awards Announced - Barchart
Becton, Dickinson And Company Earnings Preview: What To Expect - Barchart
ICP DAS-BMP Introduces Latest TPU Materials to Transform Healthcare at COMPAMED 2024 - Barchart
1 'Strong Buy' Dividend Stock That Insiders Are Buying - Barchart
Wheat Posts Monday Losses - Barchart
Beyfortus® Immunization To Protect Infants From RSV Has Begun - Barchart
Weil Group Commences Helium Production From New Alberta Facility - Barchart
F5 (NASDAQ:FFIV) Surprises With Q3 Sales, Stock Soars - Barchart
CRTC approves Google's application and paves way for annual $100 million contribution to Canadian news organizations - Barchart
Transcat (NASDAQ:TRNS) Reports Sales Below Analyst Estimates In Q3 Earnings - Barchart
Tapestry, Capri File Notice To Appeal Court Decision Blocking Their $8.5 Billion Merger - Barchart
PSP Services Inc. Announces Agreement to Acquire the NCR Atleos Debit Card Production and Transaction Processing Business in Canada - Barchart
End of the 2024 cruise season: the Port of Montreal bolsters its status as a must-visit destination in North America - Barchart
AI Platform Haiper Launches Powerful 2.0 Video Model For Increased Realism And Faster Generations - Barchart
Hologic's Quarterly Earnings Preview: What You Need To Know - Barchart
MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain - Yahoo Finance
YUL Passengers Now Have Access To CATSA's New CT Technology - Barchart
Canadian-led high seas mission finds illegal harvesting of shark fins and "dark vessels" in North Pacific - Barchart
Why Is MicroStrategy (MSTR) Stock Rocketing Higher Today - Barchart
Autonomix’s Stock Rallies On Strong Trial Results: Retail Sentiment Soars - Barchart
Should You Buy Microsoft Stock Before It Reports Earnings? - Barchart
What You Need To Know Ahead Of Micron Technology's Earnings Release - Barchart
3 Stocks That Goldman Sachs Expects To Beat The Market In 2025 - Barchart
“Top Biotech Opportunities: RVNC, HCTI, GLUE, PRSO, CRDL, Showing Promising Developments” - Barchart
Here's What To Expect From Accenture's Next Earnings Report - Barchart
Apple, Microsoft, Google, Meta, Amazon: How’s Retail Feeling About These Big Tech Stocks Ahead Of Earnings This Week? - Barchart
CMA Calls For Elimination Of Sick Note Requirements By Employers - Barchart
Hope for Chemo Patients: New Pre-Clinical Study Shows Mira Pharmaceuticals Ketamir-2 Beats Competitors' Chemo Pain Reduction by Over 60% - Barchart
Stock market today: Rising tech stocks send Nasdaq to a record as most of Wall Street stumbles - Barchart
Ketamir-2 shows promise in preclinical pain study - Investing.com India
MAXSUN 800 SERIES MOTHERBOARD LAUNCH EVENT HELD IN BEIJING - Barchart
Soleno Therapeutics To Participate In Upcoming November Investor Conferences - Barchart
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain - Brazosport Facts
Ranger Energy: Q3 Earnings Snapshot - Barchart
Uranium Royalty Acquires Existing Royalty on Cameco's Advanced Stage Millennium and Cree Extension Uranium Projects - Barchart
Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews
Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024 - Market Exclusive
Real Estate Sector Outperforms: 3 Stocks To Gain Exposure - Barchart
Mira Pharmaceuticals reports preclinical success with Ketamir-2 By Investing.com - Investing.com Australia
Ketamir-2 from MIRA Pharmaceuticals Raises the Bar in Pain Management, Outshining FDA-Approved Treatments - Barchart
Mira Pharmaceuticals reports preclinical success with Ketamir-2 - Investing.com India
CRTC Sets Rates That Will Allow For Greater Choice Of Internet Services - Barchart
Mega-Cap Tech Stocks To Buy For AI Growth: AMZN And META - Barchart
Newell Earnings Meet Estimates In Q3, Core Sales Decline 1.7% Y/Y - Barchart
Retail's Bearish Sentiment On Tesla Aggravates Even As Stock Extends Post-Earnings Rally - Barchart
Toronto Stock Exchange, Volatus Aerospace Inc., The View From The C-Suite - Barchart
Triple Negative Breast Cancer Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | ModernaTX, Inc., OncoTherapy Science, Phoenix Molecular - Barchart
EHP FUNDS INC. ANNOUNCES RESULTS OF UNITHOLDER MEETING FOR EHP SELECT ALTERNATIVE FUND - Barchart
Sustainable Pharmaceutical Packaging Market Top Business Strategy, Industry Growth Factors, Latest Trends and Future Opportunities Analysis - Barchart
Olin: Q3 Earnings Snapshot - Barchart
1.03%
1.71%
자본화:
|
볼륨(24시간):